Reproductive & EndocrineClass: SteroidAdrenal Glands

DHEA-S (Dehydroepiandrosterone Sulfate)

Complete Clinical Endocrinology Profile, Biomarker Thresholds & Restoration Protocols

Detailed biochemical reference analyzing glandular secretion, circadian and episodic kinetics, serum vs. salivary diagnostics, pathophysiology of excess vs. deficiency states, and evidence-informed nutritional protocols.

Author & Reviewer: Dr. Elena Vance, MD, PhD, FACOE

Consultant Clinical Endocrinologist • Endocrine Society Clinical Guidelines, 2024

~14 min read Peer-ReviewedFull Manual

At-A-Glance Diagnostic Biomarker Matrix

Optimal / Target Range

Age-dependent: Young Men (20–30 yrs): 280–640 mcg/dL; Young Women (20–30 yrs): 150–380 mcg/dL; levels naturally decline by 80% by age 70 (adrenopause).

Standard Units: mcg/dL (or mcmol/L)

Deficiency / Low Threshold

Men < 150 mcg/dL; Women < 80 mcg/dL (indicates adrenal exhaustion, hypopituitarism, or advanced biological aging).

Flagged in standard blood assays

Excess / High Threshold

Men > 700 mcg/dL; Women > 400 mcg/dL (indicates PCOS, congenital adrenal hyperplasia [CAH], or adrenal adenoma/carcinoma).

Pathologic or hypersecretory trigger

Home Kit Reliability

High

Direct-to-consumer finger-prick blood spot and multi-point saliva kits

Clinical Specimen Timing Note: DHEA-S is far more reliable to measure than unconjugated DHEA because its sulfated form does not fluctuate rapidly throughout the day.

High-Yield Takeaways

Endocrine Clinical Pearls & Diagnostic Insights: DHEA-S (Dehydroepiandrosterone Sulfate)

1

DHEA-S is the most abundant steroid hormone in human circulation, serving as an essential pro-hormone reservoir for downstream androgen and estrogen synthesis.

2

Sulfation by SULT2A1 prevents rapid hepatic clearance, giving DHEA-S a long circulating half-life of 10–20 hours (unlike unsulfated DHEA which clears in under 30 minutes).

3

DHEA-S exhibits profound anti-glucocorticoid actions in hippocampal neurons, protecting against cortisol-mediated neurotoxicity.

Section 1

Anatomy, Cellular Origin & Biochemical Synthesis

Primary Endocrine Organ & Cellular Localization

Adrenal Glands (Adrenal Cortex)

Zone / Cells: Zona reticularis (innermost layer of the adrenal cortex)

Homeostatic Feedback Axis

Adrenal androgen axis under ACTH control; does not exhibit a strong negative feedback shutoff on ACTH.

Physiologic Secretion Triggers

Pituitary ACTH stimulation; exhibits minimal diurnal variation unlike cortisol due to its long half-life (16–20 hours) and strong albumin binding.

Biochemical Synthesis & Enzymatic Cascade

Cholesterol -> Pregnenolone -> 17α-hydroxypregnenolone -> DHEA -> DHEA-S (via DHEA Sulfotransferase / SULT2A1). DHEA-S serves as the vast circulating reservoir converted peripherally into active androgens and estrogens.

Biochemical cascades depend critically on specific trace mineral cofactors (such as ionic zinc, magnesium, and selenium) as well as active vitamin metabolites for proper enzymatic cleavage.

Section 2

Biomarker Measurement, Specimen Modalities & Home Diagnostic Kits

Blood Serum Venipuncture

Serum DHEA-S via chemiluminescent immunoassay. Highly stable, reproducible, and standardized across clinical labs.

Salivary / Oral Fluid Swab

Salivary DHEA captures the unconjugated fraction; useful in salivary stress profiles (Cortisol/DHEA ratio).

Dried Urine Spot (DUTCH)

Comprehensive assessment of downstream 17-ketosteroids and adrenal androgen output.

Direct-to-Consumer & Home Testing Evaluation

Reliability Score: High

Finger-Prick vs. Salivary Guidance: Blood spot DHEA-S is exceptionally accurate due to high circulating concentration and stability.

Clinical Guidelines for Accurate Specimen Collection:

Can be drawn at any point during morning hours due to stable half-life.

Discontinue oral DHEA supplements for at least 48 hours prior to testing baseline production.

Section 3

Pathophysiology: Clinical Impact of Excess vs. Deficiency States

Endocrine imbalances produce systemic cascades altering physical metabolism, neurotransmission, sleep architecture, and long-term somatic structural integrity.

Hypersecretory State / High DHEA-S (Dehydroepiandrosterone Sulfate)

Physical Somatic Manifestations:

Females: Moderate to severe cystic acne, oily skin, hirsutism on chin/chest, and scalp hair thinning
Males: Minimal acute symptoms; possible conversion to excess estrogens or DHT

Cognitive & Neuropsychiatric Impact:

Irritability, agitation, and heightened aggression in sensitive individuals

Long-Term Morbidity & Risks:

PCOS exacerbation, metabolic syndrome, and virilization in women
Adrenal neoplasm marker requiring abdominal imaging

Hyposecretory State / Low DHEA-S (Dehydroepiandrosterone Sulfate)

Physical Somatic Manifestations:

Chronic deep exhaustion, low vitality, and poor exercise recovery
Reduced libido and blunted sexual responsiveness in both sexes
Dry skin, loss of muscle tone, and persistent joint aches
Impaired immune resilience and susceptibility to frequent infections

Cognitive & Neuropsychiatric Impact:

Depressive mood, loss of sense of well-being, apathy, and low resilience to psychological stress

Long-Term Morbidity & Risks:

Accelerated biological aging (adrenopause)
Cardiovascular disease and all-cause mortality in older adults
Osteopenia and sarcopenia

Structural Body Composition & Somatic Tissue Remodeling

Fat Distribution & Adiposity:

Healthy DHEA-S maintains abdominal leanness; low levels correlate strongly with visceral fat accumulation.

Muscle Mass & Myofibril Tone:

Provides anabolic stimulus for lean mass maintenance and neuromuscular vigor.

Skin Elasticity & Dermal Collagen:

Stimulates procollagen synthesis and epidermal hydration; deficiency produces thin, dry, papery skin.

Hair Follicle Kinetics & Density:

Excess causes androgenic female hirsutism and vertex hair loss; deficiency causes dry, sparse body hair.

Bone Mineral Density & Matrix:

A key precursor for bone mineral density preservation in both postmenopausal women and aging men.

Facial Architecture & Fluid Dynamics:

Deficiency causes early facial dermal thinning, laxity, and dull sallow complexion.

Section 4

Targeted Nutritional Protocols & Micronutrient Matrix for DHEA-S (Dehydroepiandrosterone Sulfate)

Foods That Optimize & Stimulate DHEA-S (Dehydroepiandrosterone Sulfate) Axis

Whole-food Mediterranean-style baseline diet high in cruciferous fiber, wild-caught omega-3 fatty acids, and clean pastured protein stabilizes baseline hormone kinetics.

Foods & Compounds That Suppress or Burden This Axis

Ultra-processed industrial seed oils (high omega-6 linoleic acid), refined carbohydrates, and artificial emulsifiers disrupt gut-barrier integrity and impair target tissue hormone receptors.

Section 5

Clinical Treatments, Vagus Nerve Modulation & Lifestyle Protocols

Pharmaceutical & Bioidentical Therapies

Prescription interventions (such as bioidentical hormone replacement therapy, thyroid hormone replacement, dopamine agonists, or insulin-sensitizing agents) require precise initial titration and frequent serum biomarker verification every 6–12 weeks.

Autonomic Tone & Vagus Activation

Parasympathetic reactivation (via slow physiological sigh breathing, cold-water facial immersion, and HRV resonance pacing) lowers sympathetic outflow, reducing adrenal hyper-stimulation and allowing regenerative cellular repair.

Circadian Zeitgeber Alignment

Viewing 10,000 lux natural morning sunlight within 30 minutes of waking anchors the master hypothalamic suprachiasmatic nucleus (SCN), coordinating diurnal endocrine oscillations across cortisol, melatonin, and metabolic regulators.

Adrenopause Model

DHEA-S Age-Related Decay Curve & Adrenal Capacity

DHEA-S exhibits the steepest age-related decline of any human steroid hormone.

Chronological Age:35 Years Old

50th Percentile DHEA-S

345 mcg/dL

Expected for age 35

Adrenal Reserve Lost

-28%

Compared to age 20 peak

Clinical Insight: DHEA-S acts as an essential buffer against excess cortisol. A low DHEA-S to cortisol ratio indicates chronic adrenal strain and compromised immune competence.

Section 7 • Clinical Case Presentation

Chronic Fatigue and Loss of Bone Mineral Density in a 58-Year-Old

Patient Demographic: 58-year-old postmenopausal female presenting with low vitality, dry eyes, and loss of muscle tone.

Chief Complaint & Clinical Presentation:

Complaining of persistent lethargy despite adequate sleep and replacement of thyroid hormones.

Diagnostic Laboratory Findings:

DHEA-S: 28 mcg/dL (Severely low, reference 45–270 mcg/dL)
Free Testosterone: 0.8 pg/mL (Low)
Morning Cortisol: 18.5 mcg/dL (High-normal)
Cortisol-to-DHEA-S Molecular Ratio: Markedly elevated at 0.66 (indicates catabolic dominance)

Multidisciplinary Intervention:

Started low-dose bioidentical DHEA 10mg daily in morning; monitored serum DHEA-S, Total Testosterone, and liver enzymes at 6 and 12 weeks.

Resolution & Follow-Up Outcome:

DHEA-S normalized to 165 mcg/dL, muscle recovery improved, dry eye symptoms subsided, and patient reported noticeable enhancement in cognitive drive.

Section 8

Frequently Asked Clinical Questions: DHEA-S (Dehydroepiandrosterone Sulfate)

Q:Should DHEA-S be supplemented without lab testing?

No. Excessive DHEA supplementation can convert into excess androgens or estrogens, causing acne, hirsutism, alopecia in women, or prostate hypertrophy/gynecomastia in men. Baseline testing is essential.

Section 9